Literature DB >> 33113258

Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting.

Tristan Barrett1, Anwar R Padhani2, Amit Patel3, Hashim U Ahmed4,5, Clare Allen6, Harry Bardgett7, Jane Belfield8, Mrishta Brizmohun Appayya6, Thomas Harding9, Ornella-Shanin Hoch9, Julian Y Keanie10, Sidath H Liyanage11, Marianthi-Vasiliki Papoutsaki6, Shonit Punwani6, Mark J C Robinson12, Arumugam Rajesh13, John N Stafurth14, Jan van der Meulen15, Jonathan Richenberg16.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33113258     DOI： 10.1111/bju.15285

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  12 in total

1.  The need for standardization of reporting in prostate MRI.

Authors:  Baris Turkbey; Bradford J Wood
Journal:  Nat Rev Urol       Date:  2021-04       Impact factor: 14.432

Review 2.  Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway.

Authors:  Tristan Barrett; Maarten de Rooij; Francesco Giganti; Clare Allen; Jelle O Barentsz; Anwar R Padhani
Journal:  Nat Rev Urol       Date:  2022-09-27       Impact factor: 16.430

3.  Structured approach to resolving discordance between PI-RADS v2.1 score and targeted prostate biopsy results: an opportunity for quality improvement.

Authors:  Rohith Arcot; Sitharthan Sekar; Srinath Kotamarti; Madison Krischak; Zoe D Michael; Wen-Chi Foo; Jiaoti Huang; Thomas J Polascik; Rajan T Gupta
Journal:  Abdom Radiol (NY)       Date:  2022-06-08

4.  What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.

Authors:  Thaisa Gvozdenovic Medina Bricio; Gabriel Lion Gouvea; Rafael Vasconcelos Barros; Fernando Chahud; Jorge Elias; Rodolfo B Reis; Valdair F Muglia
Journal:  Cancer Imaging       Date:  2022-05-03       Impact factor: 5.605

5.  Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.

Authors:  Nikita Sushentsev; Joshua D Kaggie; Rhys A Slough; Bruno Carmo; Tristan Barrett
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

6.  Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.

Authors:  Nikita Sushentsev; Iztok Caglic; Leonardo Rundo; Vasily Kozlov; Evis Sala; Vincent J Gnanapragasam; Tristan Barrett
Journal:  Br J Radiol       Date:  2021-09-19       Impact factor: 3.039

7.  MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance.

Authors:  Nikita Sushentsev; Leonardo Rundo; Oleg Blyuss; Vincent J Gnanapragasam; Evis Sala; Tristan Barrett
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

8.  Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance.

Authors:  Nikita Sushentsev; Leonardo Rundo; Oleg Blyuss; Tatiana Nazarenko; Aleksandr Suvorov; Vincent J Gnanapragasam; Evis Sala; Tristan Barrett
Journal:  Eur Radiol       Date:  2021-07-13       Impact factor: 5.315

Review 9.  Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score.

Authors:  Francesco Giganti; Veeru Kasivisvanathan; Alex Kirkham; Shonit Punwani; Mark Emberton; Caroline M Moore; Clare Allen
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

Review 10.  Optimal biopsy approach for detection of clinically significant prostate cancer.

Authors:  Simona Ippoliti; Peter Fletcher; Luca Orecchia; Roberto Miano; Christof Kastner; Tristan Barrett
Journal:  Br J Radiol       Date:  2021-08-06       Impact factor: 3.039
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.